Vectura Group Stock Price, News & Analysis (LON:VEC)

GBX 102.30 1.70 (1.69 %)
(As of 12/12/2017 02:51 AM ET)
Previous CloseGBX 100.60
Today's RangeGBX 99.55 - GBX 104.50
52-Week RangeGBX 86.50 - GBX 166.97
Volume3.61 million shs
Average Volume2.28 million shs
Market Capitalization£698.02 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Vectura Group (LON:VEC)

Vectura Group logoVectura Group plc is engaged in research, development and commercialization of therapeutic products and drug delivery systems for human use. The Company's products include Ultibro Breezhaler (European Union (EU) and Rest of World (RoW)) - LABA-LAMA; Seebri Breezhaler (EU and RoW) - LAMA; AirFluSal Forspiro (EU and RoW) - ICS-LABA; ADVATE (Global) - Antihaemophilic Factor (Recombinant); Adept (Global) - Icodextrin; Anoro Ellipta (Global) - LAMA-LABA; Relvar Ellipta/Breo Ellipta (Global) - ICS-LABA, and Incruse Ellipta (Global) - LAMA. Its product pipeline includes VR588, VR475, VR647, VR942, VR179, VR736, VR096, VR876, VR315, VR506, VR632, Seebri Neohaler and VR465. Its dry powder inhalers (DPI) include GyroHaler, Lever-operated, Open-inhale-close and Unit Dose DPI. Its smart nebuliser delivery systems provide targeted inhalation therapy for applications where precise and targeted delivery of a drug to the lungs is needed. Its smart nebulizer delivery systems include AKITA JET and FOX.

Receive VEC News and Ratings via Email

Sign-up to receive the latest news and ratings for VEC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Generic Pharmaceuticals
Sub-IndustryN/A
SectorGeneric Pharmaceuticals
SymbolLON:VEC
CUSIPN/A
Phone+44-1249-667700

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSN/A
Net IncomeN/A
Net Margins-48.35%
Return on Equity-11.44%
Return on Assets-9.24%

Miscellaneous

EmployeesN/A
Outstanding Shares679,350,000

Vectura Group (LON:VEC) Frequently Asked Questions

What is Vectura Group's stock symbol?

Vectura Group trades on the London Stock Exchange (LON) under the ticker symbol "VEC."

Where is Vectura Group's stock going? Where will Vectura Group's stock price be in 2017?

10 brokers have issued 1-year price objectives for Vectura Group's stock. Their predictions range from GBX 150 to GBX 225. On average, they expect Vectura Group's stock price to reach GBX 185.25 in the next twelve months. View Analyst Ratings for Vectura Group.

Who are some of Vectura Group's key competitors?

Who are Vectura Group's key executives?

Vectura Group's management team includes the folowing people:

  • James Ward-Lilley, Chief Executive Officer, Executive Director (Age 51)
  • Andrew Derodra, Chief Financial Officer, Director (Age 49)
  • David Lescuyer, Executive Vice President – Oral Business
  • Gonzalo De Miquel, Chief Medical Officer & Executive Vice President - Development
  • Geraldine Venthoye, Executive Vice President - Pharmaceutical Development Appointment
  • John Murphy, General Counsel ,Company Secretary (Age 62)
  • Joanne Hombal, Director of Human Resources (Age 42)
  • Roger Heerman, Chief Commercial Officer (Age 43)
  • Bruno F. J. Angelici, Non-Executive Chairman of the Board (Age 70)
  • Frank C. Condella Jr., Non-Executive Vice Chairman of the Board (Age 61)

How do I buy Vectura Group stock?

Shares of Vectura Group and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Vectura Group's stock price today?

One share of Vectura Group stock can currently be purchased for approximately GBX 102.30.

How big of a company is Vectura Group?

Vectura Group has a market capitalization of £698.02 million.

How can I contact Vectura Group?

Vectura Group's mailing address is One Prospect West, CHIPPENHAM, SN14 6FH, United Kingdom. The company can be reached via phone at +44-1249-667700.


MarketBeat Community Rating for Vectura Group (VEC)

Community Ranking:  4.1 out of 5 (star star star star)
Outperform Votes:  684 (Vote Outperform)
Underperform Votes:  152 (Vote Underperform)
Total Votes:  836
MarketBeat's community ratings are surveys of what our community members think about Vectura Group and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Vectura Group (LON:VEC) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.642.642.642.67
Ratings Breakdown: 1 Sell Rating(s)
2 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
2 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
2 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
1 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: GBX 189.67GBX 189.67GBX 209GBX 214

Vectura Group (LON:VEC) Consensus Price Target History

Price Target History for Vectura Group (LON:VEC)

Vectura Group (LON:VEC) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
11/16/2017J P Morgan Chase & CoReiterated RatingOverweightView Rating Details
11/15/2017Peel HuntReiterated RatingHoldGBX 160View Rating Details
11/9/2017Panmure GordonReiterated RatingBuyGBX 150View Rating Details
11/9/2017Numis SecuritiesLower Price TargetBuyGBX 205 -> GBX 170View Rating Details
11/9/2017Shore CapitalReiterated RatingBuyView Rating Details
9/18/2017CitigroupLower Price TargetBuyGBX 200 -> GBX 180View Rating Details
6/29/2017N+1 SingerReiterated RatingHoldView Rating Details
4/25/2017Royal Bank of CanadaDowngradeUnderperformView Rating Details
4/4/2017Stifel NicolausReiterated RatingBuyGBX 225View Rating Details
3/21/2017InvestecReiterated RatingBuyGBX 220View Rating Details
11/29/2016FinnCapReiterated RatingBuyGBX 225View Rating Details
(Data available from 12/12/2015 forward)

Earnings

Earnings History for Vectura Group (LON:VEC)


No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Vectura Group (LON:VEC) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Vectura Group (LON:VEC)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Vectura Group (LON VEC) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for Vectura Group (LON:VEC)

Vectura Group (LON VEC) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/8/2017Andrew DerodraInsiderBuy156GBX 96£149.76
10/6/2017Andrew DerodraInsiderBuy142GBX 106£150.52
9/12/2017Bruno AngeliciInsiderBuy70,000GBX 99£69,300
9/8/2017Andrew DerodraInsiderBuy158GBX 94£148.52
9/7/2017Andrew DerodraInsiderBuy82,000GBX 90£73,800
8/4/2017Andrew DerodraInsiderBuy135GBX 111£149.85
6/6/2017Andrew DerodraInsiderBuy135GBX 111£149.85
5/5/2017Andrew DerodraInsiderBuy105GBX 143£150.15
4/6/2017Andrew DerodraInsiderBuy99GBX 152£150.48
2/6/2017Andrew DerodraInsiderBuy111GBX 135£149.85
9/30/2016Andrew DerodraInsiderBuy30,000GBX 138£41,400
9/27/2016Trevor PhillipsInsiderSell240,841GBX 139£334,768.99
9/26/2016Bruno AngeliciInsiderBuy80,000GBX 143£114,400
7/7/2016Derodra,AndrewInsiderSell263,364GBX 152£400,313.28
6/17/2016Derodra,AndrewInsiderSell419,661GBX 154£646,277.94
6/13/2016Derodra,AndrewInsiderSell279,774GBX 157£439,245.18
7/7/2015Oakley,Andrew J.InsiderBuy1,000GBX 180£1,800
1/15/2015Trevor PhillipsInsiderSell171,777GBX 144.50£248,217.77
(Data available from 1/1/2013 forward)

Headlines

Vectura Group (LON VEC) News Headlines

Source:
DateHeadline
Vectura Group PLC (VEC) Given Average Recommendation of "Buy" by AnalystsVectura Group PLC (VEC) Given Average Recommendation of "Buy" by Analysts
www.americanbankingnews.com - November 30 at 9:56 PM
Vectura Group Appoints Juliet Thompson As Non-Executive DirectorVectura Group Appoints Juliet Thompson As Non-Executive Director
www.morningstar.co.uk - November 29 at 10:36 AM
Vectura Reports Positive Study Results For Ultibro BreezhalerVectura Reports Positive Study Results For Ultibro Breezhaler
www.morningstar.co.uk - November 27 at 8:28 AM
Vectura Group PLCs (VEC) "Hold" Rating Reaffirmed at Peel HuntVectura Group PLC's (VEC) "Hold" Rating Reaffirmed at Peel Hunt
www.americanbankingnews.com - November 25 at 10:10 AM
Vectura Group PLC (VEC) Receives Overweight Rating from J P Morgan Chase & CoVectura Group PLC (VEC) Receives Overweight Rating from J P Morgan Chase & Co
www.americanbankingnews.com - November 19 at 10:47 AM
Vectura Group PLC (VEC) PT Lowered to GBX 175 at J P Morgan Chase & CoVectura Group PLC (VEC) PT Lowered to GBX 175 at J P Morgan Chase & Co
www.americanbankingnews.com - November 12 at 10:20 PM
Andrew Derodra Buys 156 Shares of Vectura Group PLC (VEC) StockAndrew Derodra Buys 156 Shares of Vectura Group PLC (VEC) Stock
www.americanbankingnews.com - November 9 at 12:34 PM
Vectura Group PLC (VEC) Stock Rating Reaffirmed by Panmure GordonVectura Group PLC (VEC) Stock Rating Reaffirmed by Panmure Gordon
www.americanbankingnews.com - November 9 at 7:58 AM
Numis Securities Ltd Lowers Vectura Group PLC (VEC) Price Target to GBX 170Numis Securities Ltd Lowers Vectura Group PLC (VEC) Price Target to GBX 170
www.americanbankingnews.com - November 9 at 7:58 AM
Vectura Group PLC (VEC) Receives Average Rating of "Buy" from BrokeragesVectura Group PLC (VEC) Receives Average Rating of "Buy" from Brokerages
www.americanbankingnews.com - November 5 at 7:16 PM
Does Zero-Debt Make Vectura Group plc (LSE:VEC) A Financially Strong Company?Does Zero-Debt Make Vectura Group plc (LSE:VEC) A Financially Strong Company?
finance.yahoo.com - November 4 at 6:09 AM
Vectura Group PLC (VEC) Receives Average Rating of "Buy" from AnalystsVectura Group PLC (VEC) Receives Average Rating of "Buy" from Analysts
www.americanbankingnews.com - October 11 at 10:32 PM
Insider Buying: Vectura Group PLC (VEC) Insider Purchases 142 Shares of StockInsider Buying: Vectura Group PLC (VEC) Insider Purchases 142 Shares of Stock
www.americanbankingnews.com - October 10 at 7:22 AM
Vectura Group PLC (VEC) Stock Rating Reaffirmed by Numis Securities LtdVectura Group PLC (VEC) Stock Rating Reaffirmed by Numis Securities Ltd
www.americanbankingnews.com - October 8 at 7:34 AM
Vectura Group PLC (VEC) PT Lowered to GBX 180 at J P Morgan Chase & CoVectura Group PLC (VEC) PT Lowered to GBX 180 at J P Morgan Chase & Co
www.americanbankingnews.com - September 23 at 5:58 PM
Pulmatrix Receives Key Patents on its Inhaled Drug Delivery Technology and its COPD DrugPulmatrix Receives Key Patents on its Inhaled Drug Delivery Technology and its COPD Drug
finance.yahoo.com - September 20 at 10:49 AM
Vectura Group PLC (VEC) Given New GBX 180 Price Target at Citigroup Inc.Vectura Group PLC (VEC) Given New GBX 180 Price Target at Citigroup Inc.
www.americanbankingnews.com - September 18 at 3:54 PM
Vectura Group PLC (VEC) Given Consensus Recommendation of "Buy" by BrokeragesVectura Group PLC (VEC) Given Consensus Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - September 16 at 10:56 PM
DIRECTOR DEALINGS: Vectura Chairman Buys 70000 Shares - London South East (registration) (blog)DIRECTOR DEALINGS: Vectura Chairman Buys 70000 Shares - London South East (registration) (blog)
www.lse.co.uk - September 13 at 3:47 PM
DIRECTOR DEALINGS: Vectura Chairman Buys 70,000 SharesDIRECTOR DEALINGS: Vectura Chairman Buys 70,000 Shares
www.morningstar.co.uk - September 13 at 10:55 AM
Bruno Angelici Purchases 70,000 Shares of Vectura Group PLC (VEC) StockBruno Angelici Purchases 70,000 Shares of Vectura Group PLC (VEC) Stock
www.americanbankingnews.com - September 13 at 7:42 AM
Mundipharma Presents Positive Findings From Flutiform Study - Quick FactsMundipharma Presents Positive Findings From Flutiform Study - Quick Facts
www.rttnews.com - September 12 at 11:45 AM
Vectura Partner Mundipharma Presents Positive Flutiform Data At EventVectura Partner Mundipharma Presents Positive Flutiform Data At Event
www.morningstar.co.uk - September 12 at 11:45 AM
Insider Buying: Vectura Group PLC (VEC) Insider Buys 158 Shares of StockInsider Buying: Vectura Group PLC (VEC) Insider Buys 158 Shares of Stock
www.americanbankingnews.com - September 12 at 4:22 AM
Vectura Group PLC (VEC) Receives "Hold" Rating from Peel HuntVectura Group PLC (VEC) Receives "Hold" Rating from Peel Hunt
www.americanbankingnews.com - September 10 at 10:44 PM
Vectura Group PLC (VEC) Receives "Buy" Rating from Numis Securities LtdVectura Group PLC (VEC) Receives "Buy" Rating from Numis Securities Ltd
www.americanbankingnews.com - September 10 at 10:50 AM
DIRECTOR DEALINGS: Vectura CEO Buys Shares After LossDIRECTOR DEALINGS: Vectura CEO Buys Shares After Loss
www.morningstar.co.uk - September 8 at 9:57 AM
Vectura Group PLC (VEC) Insider Andrew Derodra Purchases 82,000 SharesVectura Group PLC (VEC) Insider Andrew Derodra Purchases 82,000 Shares
www.americanbankingnews.com - September 7 at 1:26 PM
Vectura H1 Loss Widens; Announces VR410 Deal With Pulmatrix - Quick FactsVectura H1 Loss Widens; Announces VR410 Deal With Pulmatrix - Quick Facts
www.rttnews.com - September 7 at 10:43 AM
Vectura Group plc 2017 Q2 - Results - Earnings Call SlidesVectura Group plc 2017 Q2 - Results - Earnings Call Slides
seekingalpha.com - September 7 at 10:43 AM
Pulmatrix Licenses Inhaled COPD Drug PUR0200 to Vectura Group plc - PR Newswire (press release)Pulmatrix Licenses Inhaled COPD Drug PUR0200 to Vectura Group plc - PR Newswire (press release)
www.prnewswire.com - September 7 at 10:43 AM
Edited Transcript of VEC.L earnings conference call or presentation 6-Sep-17 8:30am GMTEdited Transcript of VEC.L earnings conference call or presentation 6-Sep-17 8:30am GMT
finance.yahoo.com - September 7 at 10:43 AM
UK Stocks-Factors to watch on Sept 6 - ReutersUK Stocks-Factors to watch on Sept 6 - Reuters
www.reuters.com - September 6 at 9:51 AM
Vectura Group PLC (VEC) Given "Hold" Rating at Peel HuntVectura Group PLC (VEC) Given "Hold" Rating at Peel Hunt
www.americanbankingnews.com - August 22 at 12:56 AM
Shore Capital Reiterates "Buy" Rating for Vectura Group PLC (VEC)Shore Capital Reiterates "Buy" Rating for Vectura Group PLC (VEC)
www.americanbankingnews.com - August 21 at 11:38 PM
EXTRA: Hikma Shares Hit Four-Year Low As It Trims Guidance Once AgainEXTRA: Hikma Shares Hit Four-Year Low As It Trims Guidance Once Again
www.morningstar.co.uk - August 17 at 8:58 AM
Vecturas AKITA Nebuliser To Be Used By Dynavax For Lung Cancer ProgrammeVectura's AKITA Nebuliser To Be Used By Dynavax For Lung Cancer Programme
www.rttnews.com - August 17 at 8:58 AM
Insider Buying: Vectura Group PLC (VEC) Insider Purchases 135 Shares of StockInsider Buying: Vectura Group PLC (VEC) Insider Purchases 135 Shares of Stock
www.americanbankingnews.com - August 7 at 1:20 PM
Solid Dosage Forms Will Remain Preferred in the Global Oral Controlled Release Drug Delivery Technology Market - MarketWatchSolid Dosage Forms Will Remain Preferred in the Global Oral Controlled Release Drug Delivery Technology Market - MarketWatch
www.marketwatch.com - August 2 at 8:27 AM
Vectura Group PLC (LON:VEC) Given Average Recommendation of "Buy" by AnalystsVectura Group PLC (LON:VEC) Given Average Recommendation of "Buy" by Analysts
www.americanbankingnews.com - July 28 at 10:44 PM
Vectura Group PLC (VEC) Receives Average Recommendation of "Buy" from AnalystsVectura Group PLC (VEC) Receives Average Recommendation of "Buy" from Analysts
www.americanbankingnews.com - July 3 at 10:40 PM
Peel Hunt Reiterates "Hold" Rating for Vectura Group PLC (LON:VEC)Peel Hunt Reiterates "Hold" Rating for Vectura Group PLC (LON:VEC)
www.americanbankingnews.com - July 2 at 7:46 AM
Vectura Group PLC (LON:VEC) Earns Hold Rating from N+1 SingerVectura Group PLC (LON:VEC) Earns Hold Rating from N+1 Singer
www.americanbankingnews.com - July 2 at 7:14 AM
Vectura Signs Deal With Novartis For Generic US Inhaled TherapyVectura Signs Deal With Novartis For Generic US Inhaled Therapy
www.morningstar.co.uk - June 30 at 2:10 AM
BRIEF-Zhejiang Hisun Pharmaceutical receives GMP certificate - ReutersBRIEF-Zhejiang Hisun Pharmaceutical receives GMP certificate - Reuters
www.reuters.com - June 29 at 7:45 AM
Vectura Group plc: New development and licence agreement for a US inhaled generic (VR2081) - GlobeNewswire (press release)Vectura Group plc: New development and licence agreement for a US inhaled generic (VR2081) - GlobeNewswire (press release)
globenewswire.com - June 29 at 7:45 AM
Palladio Biosciences Announces Appointment of Frank C. Condella, Jr. to Board of DirectorsPalladio Biosciences Announces Appointment of Frank C. Condella, Jr. to Board of Directors
www.businesswire.com - June 12 at 7:57 PM
Vectura Presents Positive Phase I Clinical Study Data For Inhaled Biologic VR942Vectura Presents Positive Phase I Clinical Study Data For Inhaled Biologic VR942
www.nasdaq.com - May 22 at 7:34 PM
BRIEF-Vectura says to present positive phase I data for VR942BRIEF-Vectura says to present positive phase I data for VR942
www.reuters.com - May 22 at 7:34 PM
Vectura Reaches EUR5 Million Milestone After First FOX LaunchVectura Reaches EUR5 Million Milestone After First FOX Launch
www.morningstar.co.uk - April 7 at 6:21 PM

SEC Filings

Vectura Group (LON:VEC) SEC Filings

DateFilerForm TypeView

Social Media

Social activity is not available for this stock.

Financials

Financials are not available for this stock.

Chart

Vectura Group (LON VEC) Stock Chart for Tuesday, December, 12, 2017

Loading chart…

This page was last updated on 12/12/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.